Screener / SEC EDGAR /CIK 0000103730 /10-K filed Feb 13, 2026, compared with Feb 14, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · Electronic Components

Vishay Intertechnology Inc VSH

Compare with peers Embed
The 10-K against last year's

124 changes: 7 added, 16 removed, 97 reworded, 4 quiet changes

10-K Feb 13, 2026 vs Feb 14, 2025

10-K 0000103730-26-000019 (Feb 13, 2026) vs 10-K 0000103730-25-000017 (Feb 14, 2025) Not compared: Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

123 paragraphs · 2 new · 10 reworded · 2 gone · 10-K Feb 13, 2026 against Feb 14, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 62 · 50% changed Every version of it
The acquisitions of MaxPower Semiconductor, Inc. and the Newport wafer fab, as well as the planned capacity expansions at Itzehoe and Newport, are long-term investments which were not expected to generate significant income or cash flows in the near-term, but should greatly enhance the long-term position of our MOSFETs business. Such investments have significantly increased the net asset base of our MOSFETs business without a corresponding increase in current income or cash flows. We performed a quantitative qualitative annual assessment of each of our reporting units as of September 28, 2024 in 2025 and determined that the estimated fair value of each the reporting unit exceeded its carrying value, although the MOSFETs reporting unit’s fair value exceeded its carrying value by units were not more likely than not less than 10%. Several factors, including a further decrease in our stock price, a further increase in the asset base, their respective carrying amounts. We continue to evaluate facts and other negative internal and external factors, required us circumstances to test our MOSFETs goodwill for determine if interim impairment again in the fourth fiscal quarter of 2024. As a result, we recorded a non-cash impairment charge of $66.5 million to write-off the goodwill of the MOSFETs reporting unit. analyses are necessary. If we are not able to achieve our anticipated results or we experience a sustained decline in our stock price decreases further, the fair value of our other reporting units would be adversely affected, which price, we may result in future impairment. determine that an interim impairment analysis is necessary. There is $179.0 $180.4 million of goodwill remaining on our balance sheet as of December 31, 2024. 2025. Any impairment charges would adversely affect our results of operations in the periods an impairment is recognized.
Paragraph 19 · 13% changed Every version of it
Impact on our workforce/employees due to the spread of the virus viruses or diseases and any shelter-in-place orders; and
Paragraph 99 · 9% changed Every version of it
Our failure to repurchase the 2025 Notes or 2030 Notes at a time when the repurchase is required by the applicable indenture or to pay any cash payable on future conversions of the 2025 Notes or the 2030 Notes as required by the applicable indenture would constitute a default under such indenture. A default under such indenture or the fundamental change itself could also lead to a default under agreements governing our existing and future indebtedness, including our credit facility. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase the notes or make cash payments upon conversions thereof. The repurchase of $53 million principal amount of the 2025 Notes in the fourth fiscal quarter of 2024 reduces the risk associated with the 2025 Notes.
Paragraph 68 · 7% changed Every version of it
Our credit facility limits or restricts our current and future operations and requires compliance with certain financial covenants.

MD&A

182 paragraphs · 5 new · 66 reworded · 14 gone · 10-K Feb 13, 2026 against Feb 14, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 134 · 50% changed
In September 2024, we announced restructuring actions designed, in part, to streamline business decision making. The actions We are expected to generate annualized cost savings of approximately $12 million of selling, general and administration expenses, when the actions are fully implemented by the end of 2026. However, we are also incurring additional SG&A costs associated with our strategic initiatives. See "Cost Management" above. SG&A expenses for the year ended December 31, 2025 increased versus the year ended December 31, 2024 due to higher stock-based compensation, general cost inflation, and foreign currency impacts. SG&A expenses in 2025 include an $11.3 million gain recognized upon the favorable resolution of a contingency.
Paragraph 152 · 48% changed
In order to manage our working capital and operating cash needs, we monitor our cash conversion cycle. The following table presents the components of our cash conversion cycle during the five fiscal quarters beginning with improved to 125 days in the fourth fiscal quarter of 2023 through the fourth fiscal quarter 2025, reflecting our sale of 2024: $62.2 million trade receivables and disciplined working capital management.
Paragraph 22 · 40% changed
In 2022, our Board of Directors adopted a Stockholder Return Policy, which calls for us to return at least 70% of free cash flow, net of scheduled principal payments of long-term debt, on an annual basis. We intend to return such amounts to stockholders directly, in the form of dividends, or indirectly, in the form of stock repurchases. The policy sets forth our intention, but does not obligate us to acquire any shares of common stock or declare any dividends, and the policy maybe be terminated or suspended at any time at our discretion, in accordance with applicable laws and regulations. As a result of our negative free cash flow for the fiscal year ended December 31, 2025 due primarily to our capacity expansion plans, we exceeded our intended return through quarterly cash dividends and opportunistic share repurchases. We did not repurchase any shares of common stock after the first fiscal quarter of 2025. For 2026, we expect to maintain our dividend and opportunistically repurchase shares based on U.S. available liquidity in line with this policy.
Paragraph 172 · 40% changed
The convertible senior notes due 2025 became convertible matured on December June 15, 2024 and will remain convertible until maturity. The convertible senior notes due 2030 are not currently convertible. Pursuant to the indenture governing the convertible senior notes due 2030, we will cash-settle the principal amount of $1,000 per note and settle any additional amounts in cash or shares of our common stock. 2025. Pursuant to the indenture governing the convertible senior notes due 2025 and the amendments thereto incorporated in the Supplemental Indenture dated December 23, 2020, we will cash-settle cash-settled the $41.9 million aggregate principal amount outstanding as of $1,000 per note and settle any additional amounts in shares of our common stock. We intend to finance the principal amount of any converted notes June 15, 2025. The settlement was funded using borrowings under our credit facility. No conversions have occurred shares were issued to date. We have the intent and ability to finance the principal amount of settle the convertible senior notes due 2025 using borrowings under our credit facility upon maturity of the notes. 2025.
Paragraph 132 · 37% changed
A large portion of expected growth of our Capacitors segment is in high voltage high power film capacitors used for smart grid smart-grid infrastructure projects. Accordingly, we acquired Birkelbach, which is being vertically integrated, to ensure we have adequate metalized film material required to fulfill this growing demand.
Paragraph 97 · 35% changed
We acquired leading edge silicon continue to invest to expand mid- and silicon carbide MOSFETs products with our acquisition of MaxPower in the fourth fiscal quarter of 2022. long-term manufacturing capacity for strategic product lines. We plan to use the Newport wafer fabrication facility facility, acquired in the first fiscal quarter of 2024 as the home for MaxPower 2024, to further develop and scale our SiC MOSFETs and diodes capabilities. The acquisitions of MaxPower Semiconductor, Inc. and the Newport We are also committed to building a 12-inch wafer fab, as well as the planned capacity expansions at Itzehoe and Newport, fab in Itzehoe, Germany. These are long-term investments which were not expected to generate significant income or cash flows in the near-term, but should greatly enhance the long-term position of our MOSFETs business. Despite the goodwill impairment charge recorded in 2024, we remain committed to these long-term projects.
Paragraph 89 · 35% changed
Despite the inventory correction that For most of 2024 and 2025, we are experiencing, operated in a challenging environment, in part due to distribution customers digesting high channel inventories. The fourth quarter of 2025 saw short-term market conditions improving, and the long-term prospects for our business remain favorable, and we favorable. We continue to increase manufacturing capacities for critical product lines. The increase in net revenues in 2025 is primarily due to higher sales volume. The decrease in net revenues in 2024 is was primarily due to lower sales volume and decreased average selling prices. The decrease in net revenues in 2023 was primarily sales volume-driven, partially offset by increased average selling prices.
Paragraph 36 · 34% changed
Revenues in the fourth fiscal quarter of 2025 increased versus the fourth fiscal quarter of 2024 and prior fiscal quarter primarily due to higher sales volume. Favorable foreign currency impacts also contributed to the increase versus the fourth fiscal quarter of 2024. The book-to-bill ratio and backlog increased significantly versus the prior fiscal quarter and the fourth fiscal quarter of 2024. We continue to increase capacity for critical product lines. Average selling prices, including tariff adders, decreased versus the fourth fiscal quarter of 2023 and versus the prior fiscal quarter primarily due to lower sales volume and lower average selling prices. The book-to-bill ratio increased versus the prior fiscal quarter, but orders backlog were negatively impacted by the distributor inventory correction that began in 2022 and continued through 2024. We continue to increase manufacturing capacity for critical product lines. Average selling prices decreased versus the fourth fiscal quarter of 2023 2024 and prior fiscal quarter.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 4 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors220 words changed in this paragraph; it is 39% similar to last year's version.
The acquisitions of MaxPower Semiconductor, Inc. and the Newport wafer fab, as well as the planned capacity expansions at Itzehoe and Newport, are long-term investments which were not expected to generate significant income or cash flows in the near-term, but should greatly enhance the long-term position of our MOSFETs business. Such investments have significantly increased the net asset base of our MOSFETs business without a corresponding increase in current income or cash flows. We performed a quantitative qualitative annual assessment of each of our reporting units as of September 28, 2024 in 2025 and determined that the estimated fair value of each the reporting unit exceeded its carrying value, although the MOSFETs reporting unit’s fair value exceeded its carrying value by units were not more likely than not less than 10%. Several factors, including a further decrease in our stock price, a further increase in the asset base, their respective carrying amounts. We continue to evaluate facts and other negative internal and external factors, required us circumstances to test our MOSFETs goodwill for determine if interim impairment again in the fourth fiscal quarter of 2024. As a result, we recorded a non-cash impairment charge of $66.5 million to write-off the goodwill of the MOSFETs reporting unit. analyses are necessary. If we are not able to achieve our anticipated results or we experience a sustained decline in our stock price decreases further, the fair value of our other reporting units would be adversely affected, which price, we may result in future impairment. determine that an interim impairment analysis is necessary. There is $179.0 $180.4 million of goodwill remaining on our balance sheet as of December 31, 2024. 2025. Any impairment charges would adversely affect our results of operations in the periods an impairment is recognized.

Source: Item 1A, 10-K 0000103730-26-000019 vs Item 1A, 10-K 0000103730-25-000017

MD&A159 words changed in this paragraph; it is 60% similar to last year's version.
We are focused on enhancing Our goal is to enhance stockholder value by growing our business and improving earnings per share. Since 1985, we have pursued a business strategy of growth through focused research and development and acquisitions. We plan to continue to grow our business through intensified internal growth supplemented by opportunistic acquisitions, while maintaining a prudent capital structure. To drive growth and optimize stockholder value, we plan to capitalize on the mega trends of e-mobility, sustainability, and connectivity through initiatives. We are developing have developed go-to-market strategies and are investing in and expanding the key product lines for growth that we have identified. In addition, we are strategically expanding our outsourced production of commodity products to subcontractors. At the same time, we are enhancing our channel management while investing in internal resources by adding customer-facing engineers and filling gaps in technology and market coverage. Taken together, each of these initiatives supports our Think Customer First organizational structure. To increase our internal capacity, we had planned to invest approximately $435 million in 2024. The industry recovery has been slower than expected. Accordingly, we adjusted our timetable for investments for our new 12-inch wafer fab in Itzehoe, Germany beyond 2024 and invested $320 for capital expenditures in 2024. We remain committed to our long-term plan of increasing Vishay's capacity, to assure our customers of reliable volume as they scale. We have and will continue to modulate the amount and timing of our capital expenditures in response to order flow and the timing of customer demand and qualifications. The decreased lead time for equipment and the increased subcontractor capacity are also variables that allow us to adjust our capacity spending. culture.

Source: Item 7, 10-K 0000103730-26-000019 vs Item 7, 10-K 0000103730-25-000017

Legal Proceedings81 words changed in this paragraph; it is 64% similar to last year's version.
VGSI remains Vishay GSI, Inc. ("VGSI"), a wholly owned subsidiary of the Company, is a defendant in one remaining case, litigation, 101 Frost Street Associates, L.P. v. United States Department of Energy ("USDOE") et al., pending before the United States District Court for the Eastern District of New York. The remaining original complaint was filed on June 14, 2017, and was subsequently amended multiple times, the last of which occurred on July 7, 2023 which changed the first named defendant from USDOE to United States of America. The case contains claims for recovery of response costs under CERCLA, the Comprehensive Environmental Response, Compensation, and Liability Act, and alleges that a predecessor’s manufacturing operations in the Site, Hicksville, New York (the "Site"), between 1960 and 1993, impacted groundwater beneath and downgradient of the Site. VGSI is vigorously contesting plaintiff’s claims and will aggressively prosecute its affirmative claims. claims including affirmative claims against the United States.

Source: Item 3, 10-K 0000103730-26-000019 vs Item 3, 10-K 0000103730-25-000017

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of VSH's Risk Factors and MD&A, 10-K Feb 13, 2026 against 10-K Feb 14, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
Due to our global supply chain, we are impacted by global trade disputes. In 2025, the U.S. imposed tariffs on almost all imported goods. These tariffs negatively impacted trade relationships between the governments of the U.S. and the impacted countries, specifically the People’s Republic of China. In response, many countries increased tariffs on U.S. exports and implemented other import / export barriers or prohibitions. While many of these tariffs and reciprocal tariffs have been reduced or paused, the tariffs and any similar disruptions in the global supply chain in the future may adversely impact our business by creating economic uncertainty, increasing the cost of materials, and reducing customer demand for our products.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedRisk Factors
Our business is subject to risks associated with U.S. and foreign legislation and regulations relating to imports, including quotas, duties, tariffs or taxes, and other import charges or restrictions, which could adversely affect our operations and our ability to import products. In 2025, the U.S. imposed tariffs on almost all imported goods. These tariffs negatively impacted trade relationships between the governments of the U.S. and the impacted countries, specifically the People’s Republic of China. In response, many countries increased tariffs on U.S. exports and implemented other import / export barriers or prohibitions. While many of these tariffs and reciprocal tariffs have been reduced or paused, the tariffs and any similar disruptions to the global supply chain in the future may adversely impact our business by creating economic uncertainty, increasing the cost of materials, and reducing customer and end market demand. New or revised trade agreements could require changes in operations in the long-term.
Read it in 10-K Feb 13, 2026 at sec.gov
RemovedRisk Factors
Due to our global supply chain, we are impacted by global trade disputes. The governments of the U.S. and the People’s Republic of China remain in a trade dispute that has resulted in tariffs and other trade restrictions including import / export prohibitions. Disruptions to global trade could result in customers seeking different sources of product or requiring us to seek different sources of supply. New or revised trade agreements could require changes in operations in the long-term.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedRisk Factors
Our business is subject to risks associated with U.S. and foreign legislation and regulations relating to imports, including quotas, duties, tariffs or taxes, and other import charges or restrictions, which could adversely affect our operations and our ability to import products. The U.S. has taken actions that impact U.S. trade with China, including restricting the export of certain goods and equipment to China, imposing tariffs on certain goods manufactured in China and imported into the U.S., including certain of our products. The U.S. has also threatened to impose tariffs on certain goods manufactured in Mexico and other countries. Such actions may impact our competitiveness and adversely affect the demand for these products, or if those costs cannot be passed on to our customers, could adversely impact our results of operations for affected segments and the Company as a whole.
Read it in 10-K Feb 14, 2025 at sec.gov
RewordedRisk Factors
If we are not able to achieve our anticipated results or we experience a sustained decline in our stock price decreases further, the fair value of our other reporting units would be adversely affected, which price, we may result in future impairment. determine that an interim impairment analysis is necessary.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Our failure to make cash payments upon the conversion or repurchase of the 2025 Notes or the 2030 Notes, as the case may be, as required under the terms of the applicable indenture governing such notes would permit holders of the 2025 2030 Notes or the 2030 Notes, as the case may be, to accelerate our obligations under the 2025 Notes or the 2030 Notes, as the case may be. Notes.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
The conversion of some or all of our outstanding 2.25% convertible senior notes due 2025 (the "2025 Notes") or our outstanding 2.25% convertible senior notes due 2030 (the "2030 Notes") may dilute the ownership interests of our existing stockholders.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Holders of our outstanding 2025 Notes and 2030 Notes have the right to require us to repurchase all or a portion of their 2025 Notes or 2030 Notes, as the case may be, upon the occurrence of a fundamental change at a fundamental change repurchase price equal to 100% of the principal amount of the 2025 Notes or 2030 Notes, as the case may be, to be repurchased, plus accrued and unpaid interest, if any.
Read it in 10-K Feb 13, 2026 at sec.gov
Show the other 38
RewordedRisk Factors
In addition, our ability to repurchase the 2025 Notes or the 2030 Notes or to pay cash upon conversions conversion of the 2025 Notes or 2030 Notes may be limited by law, by regulatory authority or by agreements governing our existing and future indebtedness, as described below.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Our failure to repurchase the 2025 Notes or 2030 Notes at a time when the repurchase is required by the applicable indenture or to pay any cash payable on future conversions of the 2025 Notes or the 2030 Notes as required by the applicable indenture would constitute a default under such indenture.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
Our credit facility includes restrictions on, limits or restricts, among other things, incurring indebtedness, incurring liens on assets, making investments and acquisitions, making asset sales, and paying cash dividends and making other restricted payments.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedRisk Factors
We may not have the ability to raise the funds necessary to settle conversions of our outstanding 2025 Notes and 2030 Notes in cash or to repurchase the notes upon a fundamental change or on a repurchase date, as applicable, and our current debt contains, and our future debt may contain, limitations on our ability to pay cash upon conversion or repurchase of the 2025 Notes or 2030 Notes.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
On July 4, 2025, H.R. 1 (the "Act"), a tax reconciliation act, was enacted into law in the United States. The Act did not change the U.S. federal tax rate and most of the provisions of the Act are effective for tax years beginning after December 31, 2025. We have recorded no change to the deferred U.S. taxes directly related to the Act. The Act allows the deduction in tax year 2025, or in tax years 2025 and 2026, of some previously capitalized research and development costs. We anticipate that these additional tax deductions may preclude the utilization of a U.S. foreign tax credit ("FTC") that is due to expire in 2028. As an indirect result of this change in tax law, we have recorded a valuation allowance of $9.4 million on the deferred tax asset related to this FTC. The Act made significant change of foreign GILTI income, now called net CFC tested income. We anticipate that these changes will negatively impact our effective tax rate in the future.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
In the third fiscal quarter of 2025, the Federal Republic of Germany enacted tax legislation decreasing the federal tax rate beginning in 2028 by 1% per year for five years. We have recorded deferred tax expense of $4.2 million to reduce the carrying amount of deferred tax assets in Germany based on these new rates.
Read it in 10-K Feb 13, 2026 at sec.gov
AddedMD&A
Pursuant to the credit facility, the financial maintenance covenants include (a) an interest coverage ratio of not less than 3.25 to 1; and (b) a net leverage ratio of not more than 3.25 to 1 (and a pro forma ratio of 3.00 to 1 on the date of incurrence of additional debt). Net leverage ratio reduces the measure of outstanding debt by up to $250 million of unrestricted cash.
Read it in 10-K Feb 13, 2026 at sec.gov
RemovedMD&A
The following table reconciles gross profit by segment to consolidated gross profit. Direct costs of the COVID-19 pandemic are not allocated to the segments as the chief operating decision maker's evaluation of segment performance does not include these costs (in thousands):
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
Orders are lower due to a distributor inventory correction that took longer than expected and continued through 2024. The long-term outlook for our business remains strong, although our results are weaker than prior year results.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
We have determined that substantially all unremitted foreign earnings in Germany and Israel are no longer indefinitely reinvested. These indefinite reinvestment assertions provide greater access to our worldwide cash balances to fund our growth plan and our Stockholder Return Policy, but also negatively impact our effective tax rate.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
Goodwill represents the excess of the cost of businesses acquired over the fair value of the related net assets at the date of acquisition. Goodwill is not amortized but rather is tested for impairment at least annually. These tests are performed more frequently whenever events or changes in circumstances indicate that the assets might be impaired. We perform our annual goodwill impairment test as of the first day of the fourth fiscal quarter. When performing a quantitative assessment of our reporting units, we use an equal weighting of income (discounted cash flow) and market approaches to determine fair value. There are certain execution risks to our strategic plan. These execution risks, as well as the current market price of our common stock, result in the use of a relatively high discount rate in our discounted cash flow analysis.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
During the third fiscal quarter of 2024, we identified the decrease in our share price in combination with the increase in the book value of our assets as a result of our acquisition and capital spending activities as potential indicators of impairment requiring an interim goodwill impairment test. The interim goodwill impairment test was performed as of September 28, 2024. We performed a quantitative assessment of each of our reporting units and determined that the estimated fair value of each reporting unit exceeded its carrying value, although the MOSFETs reporting unit’s fair value exceeded its carrying value by less than 10%. No goodwill impairment charges were recognized in the third fiscal quarter of 2024 as a result of the goodwill impairment test.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
During the fourth fiscal quarter of 2024, we identified the further decrease in our share price in combination with the further increase in the book value of our assets as a result of our capital spending activities as well as certain internal and external factors as potential indicators of impairment requiring an interim test of our MOSFETs reporting unit. The interim goodwill impairment test was performed as of December 31, 2024. As a result of the assessment, we determined that the estimated fair value of the MOSFETs reporting unit was less than its carrying value. As a result, we recorded a goodwill impairment charge of $66.5 million. The goodwill impairment charge is noncash in nature and does not affect our liquidity, cash flows from operating activities, or debt covenants, and will not have a material impact on future operations.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
If we are not able to achieve our anticipated results and/or if our discount rate were to increase, the fair value of our other reporting units would be adversely affected, which may result in future impairment. There is $179.0 million of goodwill remaining on the balance sheet as of December 31, 2024. We will continue to monitor our reporting units and related goodwill for any possible future noncash impairment charges.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
We continue to invest to expand mid- and long-term manufacturing capacity for strategic product lines. We have begun building a 12-inch wafer fab in Itzehoe, Germany adjacent to our existing 8-inch wafer fab, which we expect will increase our in-house wafer capacity by approximately 70% by 2028 and allow us to balance our in-house and foundry wafer supply.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
SG&A expenses for the year ended December 31, 2024 increased versus the year ended December 31, 2023 due to higher stock-based compensation and general cost inflation, partially offset by lower bonus compensation.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
The effective tax rate for the year ended December 31, 2022 was impacted by $5.9 million of tax benefits recognized for changes in uncertain tax positions following the resolution of a tax audit, $59.6 million of tax expense recognized upon the change in indefinite reversal assertion on earnings in Germany, and $33.7 million of tax benefits recognized upon the release of a valuation allowance.
Read it in 10-K Feb 14, 2025 at sec.gov
RemovedMD&A
We made the determination during the fourth fiscal quarter of 2022 that substantially all unremitted earnings in Germany were no longer indefinitely reinvested. We recorded additional tax expense during the fourth fiscal quarter of 2022 to accrue the $59.6 million of withholding taxes necessary to distribute these approximately $360.0 million of accumulated earnings to the United States.
Read it in 10-K Feb 14, 2025 at sec.gov
RewordedMD&A
Effects of changes Changes in uncertain tax positions laws and regulations $ 13,657 $ - $ - $ (5,941) Effects of changes in valuation allowances - - (33,669) Effect of change in indefinite reversal assertion - - 59,642 Tax effects of pre-tax items above - (10,299) (498) (1,802) Adjusted net earnings (loss) $ (6,614) $ 65,652 $ 342,196 $ 454,247 Adjusted weighted average diluted shares outstanding 135,737 137,741 140,246 145,495 Adjusted earnings (loss) per diluted share $ (0.05) $ 0.48 $ 2.44 $ 3.16
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Our free cash results were significantly impacted by the installment payments of the U.S. transition tax of $47.0 million in 2025, $37.6 million in 2024, and $27.7 million in 2023, and $14.8 million in 2022, respectively, and payments of foreign, withholding, foreign and claw-back withholding cash taxes of $9.4 million in 2025, $15.0 million in 2024, and $63.6 million in 2023, and $25.2 million in 2022 2023 on foreign earnings of $75.0 million, $105.0 million, and $276.8 million, and $81.2 million (net of taxes) that were repatriated to the U.S. in 2025, 2024, and 2023, and 2022, respectively.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The cost costs of products sold and selling, general, and administrative expense have been were favorably impacted for the year ended December 31, 2024 compared to 2023 and for the year ended December 31, 2023 compared to 2022 by local currency transactions of subsidiaries which use the U.S. dollar as their functional currency. 2023.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The net loss attributable to Vishay stockholders for the year ended December 31, 2024 2025 was $(9.0) million, or $(0.07) per share, compared to a net loss of $(31.2) million, or $(0.23) per share, compared to and net earnings of $323.8 million, or $2.31 per diluted share, and $428.8 million, or $2.98 per diluted share, for the years ended December 31, 2023 2024 and 2022, 2023, respectively.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The decrease increase is primarily due to decreased increased sales to distribution customers, customers in the industrial and automotive end markets, market customers, and customers in the Europe and Americas and Europe regions, partially offset by increased sales to customers in the Asia region. regions.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Cash paid for property and equipment for the year ended December 31, 2024 2025 was $320.1 million, slightly below expectations as compared to $329.4 million for delivery of some equipment was delayed until the year ended December 31, 2023. first fiscal quarter of 2026.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
The decrease increase is primarily due to decreased increased sales to distribution customers, customers in the industrial and automotive end markets, market customers, and customers in the Asia and Americas and Europe regions, partially offset by increased sales to customers in the Asia region. regions.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
For We invested $273 million for capital expenditures in 2025, we plan to spend between $300 million to $350 million, at least 70% 82% of which will be was invested in capacity expansion projects for high growth product lines, including our wafer fab expansions.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Favorable resolution of a contingency $ (11,293) $ - $ - Impairment of goodwill $ - 66,487 $ - $ - Restructuring and severance costs - 40,614 - - Impact of COVID-19 pandemic - - 546 Reconciling items affecting other income (expense):
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Pursuant to the indenture governing the convertible senior notes due 2025 and the amendments thereto incorporated in the Supplemental Indenture dated December 23, 2020, we will cash-settle cash-settled the $41.9 million aggregate principal amount outstanding as of $1,000 per note and settle any additional amounts in shares of our common stock. June 15, 2025.
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Decrease Change in volume (13.1 (11.0 Change 0.4 (10.5 Decrease in average selling prices (3.0 1.0 (0.2 (2.5 Foreign currency effects 1.9 0.1 Other (0.1 0.4 Other 0.5 (0.2 0.2 Net change (15.7 (9.8 2.0 (12.7
Read it in 10-K Feb 13, 2026 at sec.gov
RewordedMD&A
Decrease Change in volume (10.9 (5.2 Change 3.8 (12.0 Decrease in average selling prices (4.2 1.7 (1.1 (3.0 Foreign currency effects 1.6 0.0 0.7 Acquisitions 1.0 0.2 0.4 0.5 Other 0.4 (0.1 0.5 Net change (13.7 (2.7 4.6 (14.0
Read it in 10-K Feb 13, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VSH/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.